# Debate Matchup Judgment Report

**Claude Opus 5 (high)** vs **GLM-5.2 (max)**

- Paired result: **Claude Opus 5 (high)**
- Mean entertainment: `7.67 / 10`
- Judge decisions: `6` across two side-swapped debates

**Motion:** Employers should be strictly prohibited from using anonymized population-level genetic health data to shape workplace wellness programs or health-insurance design.

## Debates and evidence

- [Debate A transcript](../../../transcripts/prop_0491__claude-opus-5-high__glm-5-2__s0__tpl_placement_active_20260320f.md): PRO = **Claude Opus 5 (high)**, CON = **GLM-5.2 (max)**
- [Debate B transcript](../../../transcripts/prop_0491__glm-5-2__claude-opus-5-high__s1__tpl_placement_active_20260320f.md): PRO = **GLM-5.2 (max)**, CON = **Claude Opus 5 (high)**
- [Public judge decision table](../../../judgments/judge_results__judge_blend_20260902_finala.csv)

## Debate A

- Transcript: [read the full debate](../../../transcripts/prop_0491__claude-opus-5-high__glm-5-2__s0__tpl_placement_active_20260320f.md)
- Roles: PRO = **Claude Opus 5 (high)**, CON = **GLM-5.2 (max)**
- Judged result: Unanimous `3-0` for **Claude Opus 5 (high)**.
- Entertainment scores: `8`, `8`, `8`
- Mean signed raw margin (PRO+): `+2.43`

| Judge | Presented sides | Winner | Signed Margin (PRO+) | Normalized | Entertainment |
| --- | --- | --- | ---: | ---: | ---: |
| Gemini 3.1 Pro Preview | A = Claude Opus 5 (high) (PRO); B = GLM-5.2 (max) (CON) | Claude Opus 5 (high) | +2.8 | +2.38 | 8.0 |
| Kimi K2.6 | A = Claude Opus 5 (high) (PRO); B = GLM-5.2 (max) (CON) | Claude Opus 5 (high) | +2.0 | +2.27 | 8.0 |
| Qwen 3.7 Max | A = GLM-5.2 (max) (CON); B = Claude Opus 5 (high) (PRO) | Claude Opus 5 (high) | +2.5 | +2.12 | 8.0 |

### Judge Notes

- **Gemini 3.1 Pro Preview** (A = Claude Opus 5 (high) (PRO); B = GLM-5.2 (max) (CON)): Side A won by systematically dismantling Side B's defenses, forcing a major concession that existing laws do not prevent condition-targeted redlining, and effectively explaining why regulating 'motive' in zero-sum actuarial models is impossible. Side A's distinction that prevention requires individual identification while pricing only requires categorical data was decisive.
  Most decisive rebuttal noted: Side A's Rebuttal 2 provided a devastatingly clear explanation of why anonymized data is uniquely suited for cost-shifting (which targets categories) and poorly suited for prevention (which targets individuals).
- **Kimi K2.6** (A = Claude Opus 5 (high) (PRO); B = GLM-5.2 (max) (CON)): Side A won by demonstrating that anonymized population-level genetic data falls outside existing individual-focused anti-discrimination statutes, then showing that the benign uses CON offered were redundant while the harmful category-level cost-shifting was uniquely enabled by this data. When CON conceded the statutory gap and proposed a use-restriction alternative, A persuasively argued actuarial opacity makes motive-policing unenforceable, leaving a strict input ban as the only viable safeguard. A’s analytical distinction between prevention (targeting individuals) and pricing (targeting categories) cleanly survived the exchange as the decisive route to victory.
  Most decisive rebuttal noted: Side A’s pressure question demanding CON name the statute that reaches condition-targeted tier hikes, which forced CON’s admission in Rebuttal 2 that GINA-style laws do not cleanly cover population-level conduct. This concession collapsed CON’s load-bearing claim that existing law already prevented the harms, and A leveraged it to show the strict ban was the only enforceable remaining option.
- **Qwen 3.7 Max** (A = GLM-5.2 (max) (CON); B = Claude Opus 5 (high) (PRO)): Side B built a significantly stronger and more cohesive case. Side B effectively neutralized Side A's primary defense—that existing laws like GINA already prevent discrimination—by highlighting the crucial legal and practical distinction between individual and anonymized population-level data. Side B's explanation of the asymmetry between prevention (which requires individual targeting) and pricing (which uses categorical targeting) was highly original and devastating to Side A's claim that the data is equally useful for benign and malicious purposes. Side A's concession in Rebuttal 2 that existing law does not cleanly cover population-level conduct effectively collapsed its initial case. Side A's subsequent pivot to "transparency requirements" was less persuasive than Side B's practical arguments about the impossibility of auditing opaque, zero-sum actuarial models to enforce a narrower "middle rule."
  Most decisive rebuttal noted: Side B's Rebuttal 2, where it brilliantly explained the asymmetry between prevention and pricing to answer Side A's pressure question, and systematically dismantled the enforceability of Side A's proposed "middle rule" by pointing out the zero-sum nature of benefit budgets and the opacity of proprietary actuarial models.

## Debate B

- Transcript: [read the full debate](../../../transcripts/prop_0491__glm-5-2__claude-opus-5-high__s1__tpl_placement_active_20260320f.md)
- Roles: PRO = **GLM-5.2 (max)**, CON = **Claude Opus 5 (high)**
- Judged result: Unanimous `3-0` for **Claude Opus 5 (high)**.
- Entertainment scores: `8`, `6`, `8`
- Mean signed raw margin (PRO+): `-1.67`

| Judge | Presented sides | Winner | Signed Margin (PRO+) | Normalized | Entertainment |
| --- | --- | --- | ---: | ---: | ---: |
| Gemini 3.1 Pro Preview | A = GLM-5.2 (max) (PRO); B = Claude Opus 5 (high) (CON) | Claude Opus 5 (high) | -2.0 | -1.70 | 8.0 |
| Kimi K2.6 | A = GLM-5.2 (max) (PRO); B = Claude Opus 5 (high) (CON) | Claude Opus 5 (high) | -1.5 | -1.70 | 6.0 |
| Qwen 3.7 Max | A = Claude Opus 5 (high) (CON); B = GLM-5.2 (max) (PRO) | Claude Opus 5 (high) | -1.5 | -1.27 | 8.0 |

### Judge Notes

- **Gemini 3.1 Pro Preview** (A = GLM-5.2 (max) (PRO); B = Claude Opus 5 (high) (CON)): Side B won by systematically dismantling Side A's enforcement mechanism and exposing a fatal contradiction in Side A's framing of the motion. Side B successfully argued that if discriminatory design is invisible, Side A's use-ban only catches employers who document their data collection, while missing those who use proxy demographics. Side A's late concession that plan-design review catches silent discriminators sealed the win for Side B.
  Most decisive rebuttal noted: Side B's first rebuttal cleverly weaponized Side A's claim that genetic inputs are 'invisible in the output,' noting that this very invisibility makes Side A's proposed use-ban impossible to enforce without relying on the employer's own honest documentation.
- **Kimi K2.6** (A = GLM-5.2 (max) (PRO); B = Claude Opus 5 (high) (CON)): CON won by exposing that PRO must either read a narrow workforce-derived exception into the text of "strictly prohibited"—rendering the motion largely symbolic—or accept that the motion bans clearly benign uses of published epidemiology applied to workforce demographics. CON then drove home a perverse enforcement problem: if discriminatory outputs are invisible in plan design, a use-ban catches only transparent, documented actors while hidden reasoning slips through. PRO's closing concession that silent discriminators are already reachable under existing law strengthened CON's claim that the motion adds nothing protective while criminalizing the auditable, benevolent pathway. After the full exchange, CON had the cleaner route to victory on textual fidelity, enforcement practicality, and the beneficial-uses blindspot.
  Most decisive rebuttal noted: CON's Rebuttal 2 and Closing exposure of perverse selection: showing that PRO's use-ban would punish employers with documented, consented genetic data programs while allowing employers who reason silently from published prevalence and demographics to escape untouched, effectively making paperwork the offense rather than preventing harm.
- **Qwen 3.7 Max** (A = Claude Opus 5 (high) (CON); B = GLM-5.2 (max) (PRO)): Side A won by systematically dismantling Side B's enforcement mechanism and textual interpretation. A forced B into a dilemma: either ban the application of published epidemiology (which B refused, thus narrowing the motion's text) or admit that existing law already handles silent discriminators. A brilliantly weaponized B's closing concession to prove the motion merely punishes transparent, auditable employers while leaving bad actors to existing law. Furthermore, A's "intervention legal, evaluation illegal" frame regarding the need for aggregate data to measure program success was highly persuasive and largely unanswered.
  Most decisive rebuttal noted: Side A's Rebuttal 2 and Closing, where A turned B's "invisible output" argument against B's own paper-trail enforcement mechanism, proving it only catches honest employers, and then crushed B's closing concession that silent discriminators are already reachable under existing plan-design review.

## Technical metadata

- Evaluation scope: `judge_judge_blend_20260902_finala__debate_all_templates`
- Topic ID: `prop_0491`
- Side-swap group ID: `prop_0491__claude-opus-5-high__glm-5-2__tpl_placement_active_20260320f`
- Raw paired winner: **Claude Opus 5 (high)**
- Mean normalized margin for Claude Opus 5 (high): `+1.91`
- Complete side swap: `yes`
- Included in ratings: `yes`
